SCROLL NEWS / DISCOVERY
Search headlines
Find the stories shaping the conversation.
Results for " Diagnostic " 152 found 🔀 AI-powered Shuffle
Join Us at INVEST Digital Health for a Conversation on Consumer-Centered Care across the Healthcare Ecosystem
Register for INVEST Digital Health, scheduled for October 29 in Dallas, for an engaging discussion on the impact of consumer-centered care from diagnostics to employer benefits and more.
Lunit and Discovery Life Sciences Collaborate to Expand AI-Powered Tissue Analysis for Biopharma Research
/PRNewswire/ -- Lunit (KRX: 328130), a leading provider of AI for cancer diagnostics and precision oncology, today announced a strategic collaboration with...
Penn State, Pa. Dept. of Ag say Animal Diagnostic Lab expansion will protect farming, public health
Penn State broke ground on a $65 million expansion of its Animal Diagnostic Lab Monday, a project Pennsylvania's secretary of agriculture said will help the state continue to protect farming and public health.
In Good Health: The Evolution Of Prostate Cancer Treatment
Prostate cancer is the most commonly diagnosed cancer in American men — and the second leading cause of cancer-related deaths. One in eight men will be diagnosed in their lifetime. And Black men are more than twice as likely to die from it.Between the social stigma and misconceptions about diagnostic methods, it’s not something many men want to talk about. Some 99 percent of people diagnosed early with prostate cancer live at least 5 more years. And treatment options and guidelines are evolving rapidly.Our “In Good Health” series continues. We gather a group of doctors from three of the disciplines involved in the treatment of prostate cancer.Find more of our programs online. Listen to 1A sponsor-free by signing up for 1A+ at plus.npr.org/the1a.
Why advanced diagnostics are essential for health equity in Asia
The Asia-Pacific region faces a growing diagnostic gap. Discover how scaling advanced diagnostics can improve healthcare equity, efficiency and patient outcomes across the region.
Global Health & WASH: October 2026 Funding Opportunities (26 new opportunities)
41 opportunities on the Global Health & WASH page this cycle, 26 of them new. The health money on this page is mostly research money, and much of it is aimed at people early in their careers. Funder after funder, from the TANGO2 Research Foundation’s Research Pathways grants to the South African Medical Research Council’s Early Investigators Programme to the National Ataxia Foundation and Alex’s Lemonade Stand Foundation, is funding early-career investigators and the institutions that host them, with a clear tilt toward researchers based in or from the Global South, from AMBSO in Uganda to Kenya’s CONNECT-VAX network to Ersilia’s AI Incubator for African drug discovery. The money is organized by disease as much as by need: narrow foundations, the Parkinson’s Foundation, NTAP for neurofibromatosis, the RUNX1 Research Program for an inherited blood disorder, each run their own grant, so the question for an applicant is less which health problem you work on than which foundation owns your disease. The largest European cheques go to consortia only, with the European Innovation Council putting up to EUR €4 million behind a single healthy-ageing project and UNITE up to EUR €1 million behind each cross-border digital health team. Water sits apart, almost entirely in applied utility research: the Water Research Foundation’s cluster of USD $250,000 to $500,000 projects, each built around a utility problem from sewer laterals to reuse treatment. And the biggest single pot is public: HRSA is renewing community health center service areas with awards of up to USD $10 million each. This post is for paid subscribers. This helps support the time and effort it takes to curate and organize these opportunities. Subscribe To keep this accessible to everyone who needs it, we’re happy to offer pay what you can rates. You can find more details here. Open Opportunities 2027 Building the Field of Health Advocacy Grant, Georgia Health Initiative. *New!* *Closing soon!* Georgia Health Initiative, a nonprofit private foundation focused on health equity, is opening its 2027 Building the Field of Health Advocacy Grant to strengthen the organizations that push for healthier systems across the state. The Initiative treats advocacy as infrastructure, backing one-year projects that range from urgent responses to shifting federal policy to longer arc campaigns on housing, behavioral health, care access, and food security. It wants coalitions that elevate community voice, apply an equity lens, and arrive ready to deploy concrete strategies, and it deliberately seeks variety in issues, communities, and organizational size. The optional webinar and required lobbying training signal a funder investing in a durable field, not one grant cycle. The strongest fits are Georgia nonprofits and public agencies ready to turn advocacy readiness into systems change. Geographies: United States. Who can apply: Tax-exempt 501(c)(3) public charities, state or local government agencies, or coalitions/collaboratives using a 501(c)(3) fiscal sponsor, that work in Georgia on behalf of Georgians and align with the mission, vision, and values of Georgia Health Initiative. Only one application per organization, though an organization may be listed as a partner or subcontractor on multiple applications. Funding amount: Organizations can apply for up to USD $80,000 per project; the Initiative anticipates investing a total of USD $1.36 million. Targeted Sectors / SDGs: Governance, Policy & Advocacy · SDG3; SDG10. Deadline: October 2, 2026. Learn more and apply here. TDD Research Pathways Grant, TANGO2 Research Foundation. *New!* *Closing soon!* The TANGO2 Research Foundation, working with a founding gift from Tango2UK, is opening its TDD Research Pathways Grant to fund early-career investigators anywhere in the world who study TANGO2 Deficiency Disorder. The foundation is using this money to seed pilot work and to build a research community around a rare disorder that few labs currently study. It wants to back emerging scientists, clinicians, and trainees who will stay with this field, not one-off projects, which is why it requires a committed mentor and real institutional support and asks each applicant for a plan for future contributions. The design rewards promise and persistence over track record. The strongest fits are students, residents, postdoctoral fellows, and new investigators ready to commit to TANGO2 research. Geographies: Global. Who can apply: Early-career investigators worldwide, including undergraduate, graduate, and medical trainees, postdoctoral fellows, residents, and clinical or research fellows. Early-career investigators must hold a PhD, MD, or equivalent doctoral degree and be within 10 years of that degree or within 5 years of initiating rare disease research, engaged in postdoctoral research at an academic institution, teaching hospital, or nonprofit research institute. Currently enrolled trainees and transitional PhD candidates beginning a postdoctoral appointment at a nonprofit institution by July 1, 2026 are also eligible. All applicants must identify a qualified mentor with relevant TDD or rare disease research experience and demonstrate institutional support. Funding amount: Up to USD $15,000. Targeted Sectors / SDGs: Innovation, Science & Technology. Deadline: October 2, 2026. Learn more and apply here. Call for Expression of Interest (EOI): AMBSO Impact Research Initiative, Africa Medical and Behavioral Sciences Organization (AMBSO). *Closing soon!* The Africa Medical and Behavioral Sciences Organization is inviting expressions of interest for its Impact Research Initiative, which funds early-stage pilot studies and proof of concept work on priority health challenges. AMBSO is a Ugandan research organization backing bold ideas that can grow into larger studies, and its tracks span antimicrobial resistance, epidemic preparedness, artificial intelligence for diagnostics, HIV prevention, climate and health, cancer, maternal and child health, and non-communicable diseases. The small award size and direct-cost-only rule point to a funder that wants evidence rather than overhead, and that favors projects able to attract follow-on money or use AMBSO’s own research infrastructure. Eligibility runs worldwide, welcoming researchers and institutions inside and outside Africa. The strongest fits are researchers with a feasible pilot that generates policy-ready evidence. Geographies: Global. Who can apply: Open worldwide to researchers, academic institutions, and research organizations whose work aligns with generating high-impact health evidence. Independent researchers are eligible if affiliated with an academic or research institution. Doctoral students are encouraged to apply as part of a research team led by a faculty Principal Investigator. Community-based organizations and other eligible entities may apply. Projects may be implemented inside or outside Uganda. Funding amount: Up to USD $10,000 per project, with no minimum funding threshold. Targeted Sectors / SDGs: SDG3. Deadline: October 2, 2026. Learn more and apply here. Entrepreneurs for Resilience 2027 (E4R27), Swiss Re Foundation. *Closing soon!* Swiss Re Foundation is opening the tenth edition of Entrepreneurs for Resilience, which backs healthcare social enterprises expanding affordable, quality primary care for low-income communities across low- and middle-income countries. The Foundation is using catalytic, blended funding plus multi-year advisory to take risk out of scaling, helping proven models reach more people sustainably rather than stay stuck at pilot size. It looks to back brick-and-click enterprises that pair physical care with digital tools and build affordability through savings, payments, or microinsurance, ideally integrated with public health systems. Requiring earned revenue, real customer scale, and gender-inclusive teams signals that this is growth capital for commercially serious ventures, not seed money. The strongest fits are established, revenue-generating healthcare enterprises ready to scale access for underserved populations. Geographies: Global. Who can apply: For-profit and hybrid healthcare social enterprises serving low-income and underserved populations in low- and middle-income countries, using combined physical and digital (brick-and-click) healthcare delivery models. Applicants must demonstrate measurable social impact, generate at least 50% of income through earned revenue, have been established no later than December 2023, already serve at least 50,000 people with potential to scale, and have at least 30% low-income customers. Preference for gender-inclusive enterprises with at least one female founder or at least 30% women in management. Funding amount: Pilot funding of up to USD $45,000 for the 6-8 shortlisted social enterprises; up to USD $1 million in blended funding (up to USD $600,000 unconditional plus up to USD $400,000 conditional) shared among 3-4 finalists over a two-year implementation period; total programme funding approximately USD $1.3 million. Targeted Sectors / SDGs: Innovation, Science & Technology · SDG3; SDG5. Deadline: October 4, 2026. Learn more and apply here. Horizon HealthTech 2026, IIITD Innovation & Incubation Center. *Closing soon!* IIITD Innovation and Incubation Center is opening Horizon HealthTech 2026, a nine-month MedTech incubation cohort run under the aegis of BIRAC EDGE for founders building medical devices, diagnostics, surgical and interventional tools, or remote monitoring. The center is backing teams that already hold a validated proof of concept and want to reach a tested prototype, pairing each founder with a named expert and clinical validation through a hospital partner. What they seek to back is Indian health technology that can survive real clinical scrutiny and regulatory review, not slideware. The structure, with lab access, CDSCO guidance, IP support, and investor connects, signals a program built to make startups ready for follow-on capital. The strongest fits are early-stage MedTech teams with defensible IP and a working path from bench to bedside. Geographies: India. Who can apply: Early-stage teams/startups with a validated idea/proof of concept (TRL 3 onwards) working on medical devices, diagnostics, surgical/interventional technologies, or remote monitoring, holding IP or with potential to generate IP. Funding amount: No cash award amount is stated on the official program page. Benefits are in-kind: prototyping lab and equipment access, clinical/hospital validation (Max Healthcare), expert mentorship, CDSCO regulatory guidance, IP filing support, workspace, cloud credits and tools, and investor connects. Run under the aegis of BIRAC EDGE and builds a path to follow-on Government/VC/Angel funding. Targeted Sectors / SDGs: Innovation, Science & Technology · SDG3; SDG9. Deadline: October 5, 2026. Learn more and apply here. OpenAI AI and Teen Development Research Grant Program, OpenAI. *New!* *Closing soon!* OpenAI is opening its AI and Teen Development Research Grant Program to fund independent studies of how generative AI shapes the lives of young people ages 13 to 17. OpenAI wants a stronger evidence base on how teens actually use these tools and what that use does to their social and emotional development, so that product teams, policymakers, and regulators can act on findings rather than assumptions. It seeks work on emotion regulation, relationships, belonging, and the safeguards that keep teens safer, welcoming interdisciplinary teams and any methodology. That it will fund research whose conclusions may not favor AI providers, and prioritizes studies touching ChatGPT, signals a genuine appetite for credible outside scrutiny. The strongest fits are research groups grounded in adolescent development, well-being, and AI safety. Geographies: Global. Who can apply: Researchers aged 18 or older who are affiliated with a research institution or organization, and/or have significant experience relevant to child or adolescent development, well-being, human-computer interaction, AI impacts, or a closely related field. Multiple institutions may collaborate. OpenAI is seeking to fund research rather than for-profit initiatives and will not prioritize for-profit organizations. Funding amount: Individual research grants up to USD $1 million, totaling up to USD $5 million; maximum 10% of each grant for overhead or indirect costs. Targeted Sectors / SDGs: Social Inclusion & Community Wellbeing; Innovation, Science & Technology. Deadline: October 6, 2026. Learn more and apply here.
Is it your personality or a psychological disorder? TikTok has answers.
Maladaptive daydreaming, obsessional jealousy and misophonia are now topics of study as social media trends force psychiatrists to rethink their diagnostic “bible.”
Too many women face a "diagnostic odyssey" at the doctor's office. This $20 billion plan could change things.
U of A researchers team up to take on major health challenges
Four interdisciplinary U of A-Banner Health teams will receive up to $250,000 each to advance promising health research in cancer detection, lymphoma diagnostics, wound care and chronic pain.
A $6 Lead And 15,000 Women Reveal A Healthcare Market Failure
Xella Health integrates multi-omic diagnostics, AI, and Oura wearable data into a connected precision health platform. CEO Kelly Lacob on closing the diagnostic gap.
'The right diagnosis is unbelievably powerful': It can take years to diagnose rare diseases, and scientists are trying to fix that
Tens of millions of Americans live with rare or undiagnosed diseases. These scientists are working to deliver them better diagnostics and treatments.
A $6 Lead And 50,000 Women Reveal A Healthcare Market Failure
Xella Health integrates multi-omic diagnostics, AI, and Oura wearable data into a connected precision health platform. CEO Kelly Lacob on closing the diagnostic gap.
ADHD and autism diagnoses have surged. A massive study may help explain why
A large Danish study found that children diagnosed with ADHD or autism today more closely resemble their peers in the general population than those diagnosed 10 years ago. The shift suggests that rising diagnosis rates may partly reflect broader identification and changing diagnostic patterns, rather than only an increase in the underlying conditions.
First Diagnostic X-Rays in Space Mark New Era for Astronaut Health
A team of researchers acquired the first diagnostic X-ray images during a commercial spaceflight, demonstrating that X-ray medicine can be performed in space.
Merck Life Science Expands Bengaluru Manufacturing with €13 Million Investment
Merck Life Science is expanding its manufacturing capabilities in Bengaluru with an investment of approximately €13 million, strengthening the company’s ability to supply critical materials to customers across India and the wider Asia-Pacific region. The expansion at Merck Life Science’s Jigani site in Bengaluru will introduce biological buffer manufacturing alongside the facility’s established chemistry capabilities. The investment is designed to enable faster and more reliable access to critical materials used by customers across research, diagnostics, biotechnology and biopharmaceutical manufacturing. The development further advances Merck Life Science’s “in-region, for-region” approach, under which the company is expanding manufacturing capabilities closer to the markets and customers it serves. By adding biological buffer production in India, the Jigani expansion will broaden the site’s manufacturing capabilities while strengthening Merck Life Science’s regional supply infrastructure for the rapidly developing life sciences sector across India and Asia-Pacific. The company said the expansion reflects both the contribution of its teams and its collaboration with government and industry stakeholders. Merck Life Science acknowledged the support of India’s Department for Promotion of Industry and Internal Trade (DPIIT), the German Embassy New Delhi, and Invest India in helping strengthen life science manufacturing capabilities in the region. The investment comes as India continues to expand its role across pharmaceutical, biotechnology, diagnostics and biomanufacturing value chains, increasing demand for dependable regional access to materials supporting research and manufacturing operations. The Bengaluru expansion reinforces Merck Life Science’s focus on building manufacturing capacity within Asia-Pacific and supporting customers through a more regionalised supply network.
Vanderbilt Health to lead nationwide initiative to improve outcomes for critically ill patients
Funded via ARPA-H, CIRCLE will combine advances in diagnostics and AI to speed development of next-generation interventions that identify and respond to harmful immunoinflammatory states before life-threatening complications occur.
New Hope for Diagnosing C.T.E. in Brain Injured Patients
Scientists are developing imaging techniques and blood tests that one day may enable doctors to identify the disease definitively in living patients.
The Liquid Biopsy That Found Pancreatic Cancer Early Has a Bigger Regulatory Problem Than Its Science
PANXEON detects stage 1-2 pancreatic cancer with 87% sensitivity, but FDA's companion diagnostic pathway may be the bigger obstacle to clinical adoption.
Guardant Health (GH) Will Present 20 Abstracts At WCLC 2026
Guardant Health (NasdaqGS:GH) plans to present 20 abstracts at the World Conference on Lung Cancer 2026. The research covers liquid biopsy, methylation based detection methods, AI driven analysis and real world clinical data in lung cancer. Several abstracts focus on machine learning models aimed at assessing metastasis risk and refining diagnostic workflows for clinicians. Guardant Health's WCLC 2026 abstract slate signals broader research momentum that our work places in a wider context...
Trump administration doles out $16.8M for healthcare tech in rural Kansas
Rural healthcare in Kansas will benefit from nearly $17 million in federal dollars to expand technology such as telehealth, artificial intelligence and diagnostic tools, and expedite transportation to specialty healthcare.
Guardant Health (GH) Lands First FDA Cleared Breast Cancer Liquid Biopsy Role
Guardant Health (NasdaqGS:GH) received FDA approval for its Guardant360 CDx liquid biopsy as a companion diagnostic in advanced HR-positive, HER2-negative breast cancer. The decision makes Guardant360 CDx the first FDA approved liquid biopsy companion diagnostic for longitudinal ctDNA testing in breast cancer care. The approval is supported by clinical trial data where early detection of ESR1 mutations using Guardant360 CDx informed treatment changes for patients. The Guardant360 CDx breast...
Testing & Diagnostics Services Stocks Q2 Results: Benchmarking Guardant Health (NASDAQ:GH)
Earnings results often indicate what direction a company will take in the months ahead. With Q2 behind us, let’s have a look at Guardant Health (NASDAQ:GH) and its peers.
A machine learning system that identifies cancer cells based on how they scatter light
Cytology tests are widely used for cancer screening, but diagnosis can be challenging when tumor and non-tumor cells look very similar. Researchers from Japan developed a machine learning system that identifies tumor cells based on their white-light scattering spectra. The approach achieved high diagnostic accuracy for mesothelioma and showed potential for distinguishing several other tumor types, offering a promising approach for enhancing cytological diagnosis.
Polsky 10: UtilityInnovation Group acquired for projected $2.6B | Aura Life Science joins ISS accelerator | OrisDX launches first diagnostic product - Polsky Center for Entrepreneurship and Innovation
The Polsky 10 is a bi-weekly newsletter featuring 10 things to know from the University of Chicago’s Polsky Center.
Maui Health Foundation secures $4.1 Million to fund state-of-the-art MRI
Thanks to the generosity of three donors, Maui Health has secured $4.1 million in funding to install a new, state-of-the-art MRI system at Maui Memorial Medical Center. More than 4,500 MRI exams are performed at Maui Memorial each year, making this investment the highest imaging priority for Maui Health, and essential to protecting the community’s access to critical diagnostic imaging.
A resource to help hospitals build the business case for diagnostic stewardship
The Society for Healthcare Epidemiology of America (SHEA) has published a new resource describing how diagnostic stewardship can improve patient outcomes, strengthen hospital quality metrics and reduce ...
Yourgene Health Insight DPYD assay achieves IVDR accreditation
Yourgene Health (part of the Novacyt Group), an international molecular diagnostics company with a broad portfolio of integrated technologies and services, announces the commercial launch of its In Vitro Diagnostic Regulation (IVDR)-certified Yourgene® Insight DPYD assay, expanding the Company's clinical genetics portfolio across regulated European markets.
Yourgene Health launches Insight DPYD assay (IVDR)
Yourgene Health (part of the Novacyt Group), an international molecular diagnostics company with a broad portfolio of integrated technologies and services, announces the commercial launch of its In Vitro Diagnostic Regulation (IVDR)-certified Yourgene® Insight DPYD assay, expanding the Company's clinical genetics portfolio across regulated European markets.
Apple Health app Users to be Able to Order Labs from Quest Diagnostics
/PRNewswire/ -- Quest Diagnostics (NYSE: DGX) today announced that Apple Health app users in the United States1 will be able to conveniently purchase a...
BGI Genomics Launches "Digital Life Twin" Framework to Power Proactive Health
Commemorating BGI Group's 27th anniversary, BGI Genomics today introduced its Digital Life Twin framework alongside an advanced multi-omics diagnostic portfolio at the 2026 Global New Product Launch Event. Grounded in over two decades of population-scale genetic discoveries, the launch marks a decisive transition from traditional, reactive diagnostics to continuous, predictive health management across the entire human lifecycle.
SEERS’ AI-powered wearable ECG monitor wins Health Canada approval
SEERS, a wearable AI diagnostic monitoring company, said Monday that its AI-powered wearable electrocardiogram analysis solution mobiCARE has received a Class II Medical Device Licence (MDL) from Health Canada.Health Canada granted the licence last Thursday (local time), following an application sub
Samsung Medison Expands Women’s Health Diagnostic Portfolio With Launch of Premium Ultrasound ‘ ...
The new addition completes the HERA Z Series lineup (Z20 & Z10), empowering clinicians wit
Health Brief: The remote monitoring squeeze
Plus: Health tech dealmaking spree is spilling into digital health, with buyers targeting virtual care, diagnostics, wearables and AI.
Bio-Techne Achieves Science Based Targets Validation and Reports Significant Progress Toward Climate Goals
/PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH), a global provider of life science tools, reagents and diagnostic products, today announced significant...
AI tech uses cardiac CT scans to evaluate inflammation, predict stroke risk
AI technology developed by Caristo Diagnostics was the focus of multiple studies presented at ESC Congress 2026.
What does the Lindsay Clancy trial tell us about treating maternal mental health?
Lindsay Clancy is currently on trial for killing her three children.Prosecutors say the murders were intentional, but her defense team says she was suffering from severe postpartum psychosis -- a condition that does not have a distinct diagnosis in the Diagnostic and Statistical Manual of Mental Disorders.That's the handbook used to identify mental health conditions, so patients often have a hard time getting proper care.The case has put a spotlight on maternal mental health and how its treated by the public and healthcare professionals. What does it reveal?WBUR’s Deborah Becker contributed reporting to this episode.It was produced by Megan Lim and Karen Zamora, with audio engineering by Éowyn Fain, Hannah Gluvna and Ted Mebane. Our director is Jonas Adams.It was edited by Justine Kenin and Tinbete Ermyas.Our interim executive producer is Courtney Dorning.Support public media with NPR+ and enjoy perks for over 25 podcasts like this one. This show’s perks include bonus episodes and sponsor-free listening. Learn more at plus.npr.org.
University of Minnesota offering free vision, hearing tests at the State Fair
The U of M will be showcasing its new sensory health mobile unit at the State Fair this year — an initiative to free diagnostic care to more Minnesotans, especially in rural areas where it can be tricky to find care close to home.
Department experiments with adding ‘like’ button into radiology reporting workflows
Diagnostic radiologists rarely receive routine feedback from referring clinicians on the quality and value of their work, likely contributing to burnout and poor job satisfaction, experts write.
Imaging wait times rise after hospital system purchases private radiology practice
Intermountain Health in January finalized its acquisition of Steinberg Diagnostic Medical Imaging, a 40-year-old radiology group with a dozen locations around Las Vegas.
Imaging wait times rise after hospital system purchases private radiology practice
Intermountain Health in January finalized its acquisition of Steinberg Diagnostic Medical Imaging, a 40-year-old radiology group with a dozen locations around Las Vegas.
Boston Scientific hit by cyberattack causing ‘disruptions’ to parts of its business
This year has seen a growing number of medtechs hit by cyberattacks, and now Boston Scientific has become the latest victim. In an SEC filing posted Aug. 26, the medtech giant said it had detected a “cybersecurity incident” the day before. The incident has affected certain parts of its information technology systems, something that “has resulted in a global disruption to the company’s operations.” The incident has hit not just its information systems but also its business applications, which “support aspects of the Company’s operations,” it said in the filing. This includes its ability to process and ship customer orders. Boston Scientific said it is working to restore the systems, but the timeline remains unknown. Related Baylor Genetics hit by cybersecurity attack targeting patient, staff information As the company investigates the incident, it remains unclear how significantly its business will be affected. “Accordingly, the Company has not yet determined whether the incident is reasonably likely to have a material impact.” The company’s shares were down 3.5% in premarket trading as the news broke. This adds another layer of pressure for the medtech, which last month revealed a new global restructuring program that starts this year and is slated to be completed by 2029. The company said at the time that it “does expect some headcount reductions to result from these restructuring activities,” but did not provide any numbers or specify areas where the cuts may be made. It added, however, that new jobs are also set to be “created in areas of growth.” It was also forced to cut its sales guidance in Q2, saying in late July that it now expects full-year 2026 organic revenue growth of 5% to 6%, down from its previous guidance of 6.5% to 8%. Boston Scientific is one of a growing number of life sciences companies, notably medtechs, that have been hit by cyberattacks this year. These include Abbott, iRhythm, Medtronic and Stryker, as well as Big Pharmas Amgen and Novo Nordisk.
Monogram Health to pay $2.4M to settle Medicare Advantage upcoding allegations
The Justice Department told Healthcare Dive that Monogram, a home health company, overcharged Medicare through contracts with Cigna and Humana by inflating diagnostic codes.
The Women's Health Diagnostics Gap Isn't Missing Tests, It's Missing Answers
More than half of Function's members are women. Its co-founder explains why the women's health diagnostics gap is about interpretation, not access.
EDX Medical jumps 33% after £2.7m 'premium' fundraise to expand health screening
Shares in EDX Medical Group PLC (AQSE:EDX) soared 33% to 13p on Monday after the company raised about £2.7 million to expand its workplace health screening service. The Cambridge-based diagnostics developer, which makes digital tests aimed at detecting major diseases early, placed 19.4...
How health systems are embracing chatbots to query and summarize patient records
Several large health systems are rolling out AI chatbots to query patient records, saying they save time and increase diagnostic accuracy.
How One CEO Stepped Up to Save a Family Business
When Nubia Perez stepped into leadership in a time of uncertainty, she brought structure, vision and renewed growth to her family’s manufacturing business.
From Textile Waste to Breakthrough Innovation: The OSOMTEX Story
An inside look at how Patricia Ermecheo created OSOMTEX, pioneered textile recycling technology and rebuilt her business after burnout and loss.
Radiology Partners petitions FDA for greater clarity around imaging AI regulations
Mosaic Clinical Technologies believes diagnostic imaging vision-language models represent an “important and promising” advancement in medicine, but one that requires greater regulatory scrutiny.
FDA approves new Alzheimer’s PET imaging agent from Lantheus
Tauklarify, also known as MK-6240, is a radiodiagnostic agent indicated for positron emission tomography scans of adults suspected of having the degenerative brain disease.
Epic launches new diagnostic image exchange
Clinicians can now retrieve diagnostic-quality images from other health systems and patients can "ditch the disc," the company says. Next up: The healthcare IT giant wants TEFCA to adopt it as a standard.
Epic launches new one-click feature allowing outside hospitals to share medical images without CDs
The Verona, Wisconsin-based vendor this month is rolling out its Care Everywhere Diagnostic Image Exchange across the Epic community.
Lucid Diagnostics Provides Business Update and Reports Second Quarter 2026 Financial Results
/PRNewswire/ -- Lucid Diagnostics Inc. (Nasdaq: LUCD) ("Lucid" or the "Company") a commercial-stage, cancer prevention medical diagnostics company, and...
John Harbaugh Explains Giants' Decision to Try Out Terrion Arnold
The New York Giants broke from their traditional caution by inviting Terrion Arnold to East Rutherford for a tryout Wednesday. First-year head coach John Harbaugh explained what went into that decision and how Arnold performed while working out at the Quest Diagnostics Training Center. Arnold has now tried out for at least four teams, most recently the Giants on Wednesday, a day after working out for the New Orleans Saints.
Twelve U.S. Health Systems and Aidoc Unite to Confront America’s Diagnostic Capacity Crisis
As demand for diagnostic answers outpaces the physicians available to deliver them, health systems are collaborating with Aidoc on a shared goal: helping patients receive a safe, accurate diagnosis sooner.
University of Essex opens lab to train future scientists
The £2.5m facility includes a dedicated cancer diagnostics laboratory.
8 UCF Faculty Members to Be Inducted in Academy of Science, Engineering and Medicine of Florida
UCF faculty were recognized for their advancements and impact in artificial intelligence, medical diagnostic technology, computer science, energy and manufacturing, and coastal resiliency.
The Science Lab Where Technicians Are Drowning in Feces
Samples—and a certain stink—are accumulating at Quest Diagnostics thanks to the cyclosporiasis outbreak. “You get used to it.”
Rad Partners’ Georgia affiliate signs in-network agreement with Anthem BCBS
Northside Radiology Associates said the pact will span multiple years and ensure Anthem members continue having uninterrupted, in-network access to diagnostic and interventional care.
Editorial: Pennsylvania health insurance rates need triage
The cost of staying healthy is climbing. The cost of getting sick is even worse. Prescription drug costs are up. So is the amount of money people spend in urgent care — and that’s affordable compared with an emergency room visit. Testing, diagnostics, office visits, the little extras you don’t
Siemens Healthineers’ head of Americas steps down, GE CFO switch, new ASTRO prez, plus more leadership moves
In other news, Vanderbilt has appointed a radiologist to a key leadership position, the University of Rochester has picked a director of diagnostic imaging, and Pueblo Radiology Associates hired 7 new docs.
Giants Announce Major Upgrades to Practice Facility
The New York Giants have been much maligned for MetLife Stadium since it opened, but their practice facility in East Rutherford is getting a major overhaul. The Giants unveiled plans to enhance their facility with more than 93,500 square feet of new construction and 46,000 square feet of renovations to the Quest Diagnostics Training Center. The Giants will boost the home locker room inside their practice facility to 6,000 square feet while also enhancing their weight room to 11,000 square feet.
Vanderbilt Health and Siemens Healthineers launch $87M Value Partnership to deliver advanced technology, elevate patient care
Value Partnership will drive technology upgrades and standardization across diagnostic imaging and radiation oncology, promote workforce development Collaboration will empower health care innovation through scalable artificial intelligence uses in radiology, personalized medicine and workflow automation
Dementia affecting younger persons strikes Hispanics more than previously thought, UT Health San Antonio-led study shows
Educational disparities contribute to diagnostic delays of frontotemporal dementia Contact: Steven Lee, (210) 450-3823, lees22@uthscsa.edu SAN ANTONIO, July 27, 2026 – A form of dementia that strikes younger people is more common in Hispanics than previously thought, according to a new study led by researchers at UT Health San Antonio, the academic health center of […]
Temporal Changes in Pediatric Influenza Test Positivity Across COVID-19 Public Health Policy Phases: A Five-Year Retrospective Cohort Study
Background The COVID-19 pandemic coincided with substantial changes in respiratory virus circulation, healthcare utilization, and diagnostic testing. Although population-level influenza activ...
Ida Tin Coined Femtech. Now She’s Funding Continuous Hormone Monitoring
Femtech pioneer Ida Tin is leading a €40M government challenge to build continuous hormone monitoring—and end the diagnostic delays that cost women years.
Beyond weight loss: Lilly aims for leadership in brain science
Lilly’s neuroscience chief discusses the large pharma’s aims in brain science, and how diagnostics and dosing are driving its next advancements in Alzheimer’s.
Bipartisan Bill Pushes $25M 4D Software for Veterans' Respiratory Health
Lawmakers unveiled a bipartisan bill to invest VA funds into diagnostic scanning software that could detect asthma or lung conditions.
New grant to improve discovery of potential diagnostic, therapeutic molecules
Carly Schissel, assistant professor of chemistry, is part of a multi-institution team that has been selected to receive funding from the Scialog: Automating Chemical Laboratories initiative. The initiative supports teams of early-career scientists doing fundamental science to accelerate advances in laboratory technologies using automation and artificial intelligence.
Abbott investigates two separate cyber incidents, says no operations affected
Abbott Laboratories is investigating two cyber incidents involving unauthorized access to some internal systems at its cancer diagnostics business and its LabCentral portal, the company said on Friday, adding that its operations were not affected.
Abbott discloses cyberattack on cancer diagnostics business
The cyberattack follows Abbott’s recent $21 billion purchase of Exact Sciences. Abbott did not disclose what kind of information was accessed.
Exclusive : Diagnostics log confirms iPhone 18 Pro Max camera specs ahead of launch
An ISP diagnostics log, part of the trove of internal Tata Electronics files leaked in June by the World Leaks ransomware group, confirms several previously rumored iPhone 18 Pro Max camera specs ahead of Apple's official announcement.
Diagnostic dilemma: Junk-food diet caused a teen's permanent blindness
A teen's nutrient-poor diet led to irreversible vision problems.
United States Delivers Life-Saving Health Supplies and equipment to Madagascar
United States Delivers Life-Saving Health Supplies and equipment to Madagascar U.S. Chargé d’Affaires Steve Bremner presided over a handover ceremony to the Government of Madagascar, represented by President of the Refoundation Col. Michaël Randrianirina, marking the delivery of nearly one million mosquito nets, over 900,000 pieces of critical laboratory equipment, and 33 internet connectivity systems. The assistance – valued at more than $2.2 million – is part of a broader U.S.-Madagascar health partnership, outlined in our bilateral Global Health Memorandum of Understanding (MOU) signed in December 2025, totaling $134 million from the U.S. government from 2026 through 2030. “This assistance is clear and disciplined – it is a tool of strategic engagement, not global charity,” said Chargé d’Affaires Steve Bremner. “Every U.S. taxpayer dollar must show measurable results, reduce long-term dependence on U.S. resources, and support greater self-reliance. Stronger health systems in Madagascar help detect and contain infectious diseases before they spread across borders, protecting American and Malagasy families alike.” The assistance includes: 989,250 long-lasting insecticide-treated mosquito nets - worth $2 million – will be distributed to 63 districts and 1,661 community health centers across Madagascar. Malaria remains one of the leading causes of death in the country, claiming the lives of children and women at an unacceptable rate. The third and final delivery of these nets arrived in late June and will be distributed starting this July until mid-October, ensuring that those most at risk of mosquito-borne disease now have access to this basic but life-saving protection. U.S.-funded Global Health Supply Chain Program – Procurement and Supply Management (GHSC-PSM) project will ensure the distribution. 908,523 pieces of critical medical and laboratory equipment – valued at $180,000 – including personal protective equipment, laboratory supplies, diagnostic tools, and cold chain equipment – along with a modernized digital surveillance system to Madagascar’s Ministry of Public Health. This support through the STRIDES (Strengthening Infectious Disease Detection Systems) program bolsters Madagascar’s ability to detect and respond to outbreaks of diseases such as monkeypox, plague, rabies, polio, and Ebola before they become regional or global threats. Over $30,000 of funding for the full procurement, installation, and first year of service for 33 Starlink satellite internet systems at priority districts and regional health offices across the country. These systems will allow health workers in remote and underserved communities to transmit health data quickly to central decision-makers – enabling faster, better-coordinated responses when disease outbreaks occur. U.S.-funded Momentum Country and Global Leadership (MCGL) will implement this project. As the country’s largest bilateral health donor, the United States remains committed to the principle that a stronger, healthier Madagascar makes for a stronger, safer world – and a stronger, safer America.
Oxford Brain Diagnostics Advances Vision for Measuring Brain Health and Neurodegenerative Disease with Five New Studies at AAIC 2026
New findings demonstrate the potential of OBD's MRI-based Cortical Disarray Measurement (CDM®) technology to support patient identification, disease characterization, treatment monitoring, and therapeutic development across Alzheimer's disease OXFORD, United Kingdom, July 13, 2026 (GLOBE NEWSWIRE) -- Oxford Brain Diagnostics (OBD), a leader in MRI-based measurement of brain health and neurodegenerative disease, today announced the presentation of five new studies at the Alzheimer's Association I
Generative AI chest X-ray models offer new approach to radiology reporting and quality improvement
While the technology remains investigational in many practices, researchers say it has the potential to improve diagnostic accuracy, streamline AI development and strengthen radiology quality assurance.
How Penn State Beaver is helping farmers respond sooner to animal health challenges
Penn State Beaver is helping strengthen animal health and agricultural resilience across western Pennsylvania through the Keystone Animal Diagnostic Center, which gives farmers and veterinarians closer access to critical and timely testing.
Your health insurer shouldn’t decide your treatment plan. That’s what your doctor (and possibly AI) should be doing.
With a digital health record, clinicians and AI-driven diagnostic tools would be able to see your full health history — and then make better decisions.
Breakthrough Science Meets Market Skepticism: Insight Molecular Diagnostics Inc. (IMDX)’s Defining Moment
Insight Molecular Diagnostics Inc. (NASDAQ:IMDX) is one of the high-growth micro-cap stocks to buy now. On June 11, Insight Molecular Diagnostics Inc. (NASDAQ:IMDX) announced the online publication in the American Journal of Transplantation of new data demonstrating the statistical superiority of its flagship GraftAssure transplant rejection monitoring assay. The study showed that the novel GraftAssure […]
Adaptive plots splitting Pfizer-partnered drug discovery unit from diagnostics business
Adaptive Biotechnologies is planning to separate its drug discovery and diagnostics businesses,
Radiology Partners affiliate inks in-network deal with Anthem Blue Cross
The deal is with Golden State Imaging Associates, which serves Southern California, providing 24/7 diagnostic and interventional services to hospitals and other referrers.
The science of seeing inside explosions
During the Manhattan Project, Los Alamos scientists needed a diagnostic tool. Like an x-ray confirming a broken leg bone, the researchers wanted to be able to see into the smoke cloud of detonation products. They needed to verify that the implosion remained symmetric to ensure an efficient detonation. Although it was a time when scientific breakthroughs came quickly, this challenge stumped them, and their initial efforts to use x-rays to visualize the event were limited.
Why AI Is Creating New Cybersecurity Risks For Healthcare
AI is helping hospitals improve diagnostics and patient care, but it's also giving cybercriminals new tools to target healthcare systems.
We can create the future of science right now
Paul Litvak is the founder and Executive Director of the Robyn Dawes Institute and a Visiting Scholar at UC Berkeley. He has a PhD in Behavioral Decision Research from Carnegie Mellon where he studied emotions and the sunk cost bias. Over 15 years in industry, he solved a wide range of challenging technical problems. At Meta he created models optimizing the ad review process. At Google he ran experiments to measure social influence. At Airbnb, he was a product manager leading machine learning teams optimizing search ranking and price suggestions. He also co-founded and led product at Rhythmic Health, a venture-backed biosensing startup, creating an accurate low cost system using a color changing strip and a smart phone to measure salivary lactate. The bottleneck At this point, it is uncontroversial to say that science needs to stop using the PDF article as the unit of knowledge and currency. The unbearable slowness of scientific publishing, the profit motive and margins: I’m not saying anything new. The PDF also sucks because it’s hard to extract structured information, which makes it hard to do evidence synthesis. As a result, we do much less evidence synthesis than is needed. And evidence synthesis ultimately undergirds most policy and medical decision-making. I can see second-by-second real-time odds for any sporting or newsworthy event, but a school board can’t see the best evidence on whether their 8th graders should be taught algebra. As a society, we don’t treat this as an important problem. Again, not controversial. Not only is the problem well understood, but the solution has already been laid out. What we need is AI-assisted living evidence synthesis - (1) an open knowledge graph of atomic claims, (2) claims linked to evidence, (3) assessment and synthesis of each piece of evidence, and (4) continuous updating with new data. What few realize (yet) is that the technical capacity to build this vision for a significant portion of science already exists. Not only that, scientists and startup teams are already building many of these components. I know this because I’ve been surveying the space and talking to many of the builders. There are some missing pieces: for example, evaluations of how well some of the components work. But at this point, most of what’s missing is a fully end-to-end working integration of all of these parts. In the rest of this essay, I’m going to lay out all the parts of a working living evidence layer for science and who is working on them, and propose concrete next steps for building this system. What’s now possible The diagram above outlines the components of a living evidence synthesis platform, including some of the teams working on each component1. Scientific PDFs are processed into claims with associated evidence. The evidence is subjected to a forensic audit, methodological evaluation and robustness and reproducibility checks. Finally it’s given a weight in a continuously updating synthesis. What follows is a description and status of each component and a few of the teams working on them. Document understanding The first thing you need to be able to do is turn an article into structured data. Mostly that means parsing PDFs. There are often multicolumn layouts that confuse non-specialized PDF to text processing libraries. For scientific papers, there is the added complexity of parsing formulas and tables and figures. This is a really hot area - there are startups offering APIs, and it seems like a new open source package gets posted to Github every few weeks. What follows isn’t exhaustive. A package called GROBID was the state of the art for a while, they didn’t update their package for nearly two years until very recently. In the meantime reducto.ai released an AI powered PDF extraction API, PaddleOCR became popular, IBM released a model called Docling, and both Mistral and Gemini created models and libraries. I also know of at least one other well-funded psychology research group working on a paper parser. By contrast, there are few open evals in this space, with no extensive evals for complex table comprehension in particular. Nonetheless, I’m confident this will be a solved problem soon, given the combination of LLM advances and developer interest. Hypothesis level extraction There has been increasing interest in comprehending the extracted text of papers and linking information to evidence for each hypothesis. A lot of work has already been done. Trialstreamer (Marshall et al. 2020) and RobotReviewer LIVE (Marshall et al. 2023) demonstrated automated extraction of trial population, intervention, and outcome at scale on clinical RCTs. PaperQA2 (Skarlinski et al. 2024) and Ai2 ScholarQA (2024) extended this to retrieval-augmented question answering with citation grounding. Elicit, Consensus, and SciSpace operationalized claim-level extraction for end users. OpenEval (Booeshaghi et al. 2026) is the most recent and most ambitious: 1.96 million atomic claims extracted from 16,087 eLife manuscripts using Claude Sonnet 4.5, grouped into ~299,000 results, with LLM evaluations showing 81% agreement with human peer review on a 2,487-paper subset. None of these solutions link claims to test-statistics, as you would need to evaluate randomized controlled trials. This is why I built the evidence.guide API - to extract hypotheses and associated test statistics from behavioral science papers. The best public eval of this kind of extraction I’m aware of comes from the recent SCORE project - they had humans code thousands of psychology papers to extract their claims by hand. It would be extremely helpful to the world if all scientific PDFs were available as structured open data. I’ve been working to make this happen, both directly at Berkeley and through coordination with large entities I can’t yet speak of; as hard as it is to do, I think it’s possible2. Forensic audit A lot of work has been done on forensic audit, but some gaps remain. Of course, for biology papers that rely on images for evidence, there are a variety of tools (notably Proofig and ImageTwin) to spot anomalies. These are still well short of what sleuths like Elizabeth Bik can do on her own, but these tools are constant companions among fraud analysts. There’s someone working on auditing Excel files for anomalies, and a number of teams are automating numerical checks like GRIM and SPRITE, including Scrutiny project, the INSPECT-SR team as well as statcheck. The regcheck team is building a way to use AI to compare preregistrations to analyses in papers, to ensure there aren’t significant deviations. Nonetheless, there are many other kinds of anomalies to screen for, both public and less publicly known. And there are no formal evals for anomaly detection that I’m aware of. Still, there’s a lot to draw from in this space and I’m pretty certain we will be able to scan papers for most kinds of obvious anomalies in the near future. Methodological review This area has been white hot, though I fear for many of the startups in this space, because this capability may become commoditized. There are at least six different AI peer review companies, including Refine.ink, Reviewer3, ReviewerZero.ai, Q.E.D. Science, Paper Wizard, and Isitcredible. Coarse (a pun on refine) was also recently created as an open source alternative. These systems provide qualitative feedback on the content of papers, spotting methodological weaknesses and mathematical errors. They seem to work pretty well, and many academics report bitterly that they exceed the average quality of typical peer reviewers. But there are few evals here either. What evals exist so far involve using LLM-as-judge (circularity problems abound) or comparing against human reviews of questionable quality. What you’d ideally want is an eval that measures capturing known errors in papers3. Reproducibility and robustness Another active area has been using AI agents to automate computational reproducibility4 and robustness5 checks in papers that report numerical results. For more recent papers where data and code are available, AI agents can see whether they can re-run the analyses and produce the numbers reported in the published paper. In addition to a handful of individual academics who have been experimenting using Claude Code for this, the Institute for Replication is a leading group working on building an end to end system. The evals related to this problem are the most mature, with CORE-Bench (Siegel, Kapoor, Narayanan 2024) and PaperBench (OpenAI 2025) available to benchmark agents on this task. There is also work on getting AI agents to test alternative ways of analyzing the data to ensure the results are robust to small analytic design choices. Synthesis This is the most underdeveloped area where significant investment is required. Although some automated evidence synthesis systems exist — for example, otto-sr is building an AI agent to write systematic reviews — none of these incorporate the full range of paper level signals to weight evidence appropriately. Nor is there anything like an eval or a gold standard for a good systematic review. Arguably Cochrane reviews are the closest we have to gold standard human systematic reviews, though I’ve heard academics in the know complain about their uneven quality. A key question for a synthesis platform is how to weight anomalies and methodological issues in assessing the quality of a piece of evidence. This is an unsolved problem and one I’m very keen to work on. Continuous updating There are many pieces of basic infrastructure available for monitoring for new research and initiating updates. OpenAlex is the current open citation graph. Retraction Watch integrated into Crossref in October 2023. Scite tracks how citations support, contrast, or mention prior claims. The Living Evidence Network demonstrated continuous-update workflows in clinical guidelines. Engineering this is a relatively straightforward task. When you look over this technical architecture and all the progress being made, it’s hard not to be optimistic that a living guide to scientific evidence will be built. The stakeholders are ready The social infrastructure for this is starting to coalesce — it’s not just a pie in the sky academic exercise to imagine this coming into existence. Institutions like the Center for Open Science, the Institute for Replication, the INSPECT-SR, the Living Evidence Network and more are all working on scaling work to improve research quality. Funders are also aligned. The Sloan Foundation has funded living evidence work through COS. Coefficient Giving supports the Institute for Replication and COS. The Astera Institute and the Institute for Progress have shown interest in this space. NIH has established an Office for Replication and Reproducibility. Although there are (very unfortunately) serious headwinds in science funding generally, there is an active group of funders interested in metascience. A brief word about what I’ve been doing at RDI. First, as a Visiting Scholar at Berkeley I’ve been actively figuring out how a non-profit and a public university can conduct and make public the results of large-scale academic article data mining. With some of the money I raised from donors, I commissioned a legal analysis of recent case law and publisher text data mining (TDM) agreements in order to understand whether a massive open data mining of academic articles is possible (with caveats, it is). I’ve also been working to bring together stakeholders in this space, and identify gaps. I’ve also been doing some software development in this space, with more to come. A pilot proposal The assumption undergirding all of this is that an AI, given all this information, would make the right judgment about a scientific claim with lots of conflicting evidence, weighing all the factors appropriately. That’s the hypothesis we need to test. Randomized control trial research is the best place to focus on first. RCTs are used to make many of the important decisions in society - from medical trials to public policy changes. And they use a relatively uniform set of inferential statistics with lots of known and available diagnostics. Behavioral science experiments, within the broader realm of RCTs, should be first used as a testbed whose results can be generalized. Because behavioral science is at the vanguard of open science practices, replications abound (there are thousands of them) to serve as ground truth training data. Key Hypothesis Therefore the pilot would test, in behavioral RCTs that have been replicated, whether the quality of evidence for a claim can be used to accurately predict whether that claim will replicate. Secondary Hypotheses Compared to claims that replicated, non-replicated claims demonstrate a greater share of forensic anomalies in their source literatures. Hypothesis level claim and statistic extraction is accurate enough to scale living evidence without onerous human review costs. Replication prediction is more accurate than prediction markets6 or journal prestige. If all the different quality signals we gather do accurately predict which studies will replicate, then we can use that model to score evidence to power the living evidence layer. Why this is informative regardless of outcome If the pilot succeeds, the architecture extends to medical RCTs (where Living Evidence already operates and integration is mostly about claim representation), then to slices of basic biology with stable replication structure. If it fails, the field learns which quality signals are load-bearing and which ones metascience has oversold. Either result is a contribution to knowing what the literature supports. Implications for funders Because this burgeoning ecosystem of builders already exists, a well-informed philanthropic or government funder could play a crucial catalyzing role in bringing this future about. They could play at least three roles: creating open structured datasets, publishing open benchmarks and incentivizing the solving of key technical challenges. First, open archives of papers that the government maintains, like PubMed, could be turned into structured data amenable to large scale metascience and claim aggregation. I know the US government already has an interest in doing this, though some key open questions remain unanswered. How do you determine the best models and systems for accurately extracting information from papers? How can you establish a robust way to allow researchers to flag errors and correct them? And finally, how do you create a legal regime in working with publishers to maximize the scope of available papers? For the latter, a university or a private philanthropy may be better positioned to make structured data publicly available under journal subscription terms or fair use. Philanthropists or government funders could also coordinate to create or commission benchmarks that evaluate whether important problems have been solved. For example, an open benchmark for claim extraction from a range of different scientific article types would be extremely helpful. Ensuring the underlying data are accurate is vital for creating these evaluations. I’ve discussed opportunistically using various human-created datasets for this purpose, but a consistent problem is that errors in human data make it difficult for them to serve as a gold standard. Finally, with structured data and benchmarks available, the government or private philanthropy could use them to incentivize groups to develop machine learning systems that meet these benchmarks. Prizes are one potentially valuable tool for this. For example, you could establish a prize for a system that accurately updates a living meta-analysis for a small set of claims. Prizes are particularly useful as signals of problem importance, and can help create vibrant ecosystems of public and private research—see, for example the role the government played in kickstarting the current work on nuclear fusion. Conclusion The drawbacks of the current scientific publishing system are known. Scientists agree, metascientists agree, philanthropists agree: the published PDF plus citation graph isn’t the right substrate for maintaining a representation of the evidence base in science. The pieces needed to build the alternative either already exist or are rapidly taking shape. The community is forming around exactly this problem, with concrete partnerships and shared infrastructure. A pilot should start on behavioral science RCTs because that’s the slice of empirical science most amenable to legibility, where replication ground truth is richest, and where the failure modes are best documented. What’s been missing is the galvanizing mission to assemble these pieces into something that works. That’s what I’m proposing to build. *** 1 I have a broader field map that I’ll release publicly soon. This is me, building in public! 2 If this is something that you are excited about, please reach out and talk to me. 3 More on this very soon too! 4 This tests whether, given the code and the data, you can get the same statistics as reported in the published paper. 5 This tests whether the results are the same as a paper’s given alternative analytical decisions in conducting the analysis (like outlier omission). Closely related is the idea of a “multiverse” where you come up with many different ways of answering the same underlying research question with the same data, and test whether the results hold in all those alternative methods. There’s been work on the latter as well. 6 Some of the replications, e.g. those from the SCORE project, had paired the experiments with forecasts from prediction markets. So we get to look at this for free.
New study casts doubt on reliability of mental health diagnosis interviews
Diagnostic interviews seen as ‘gold standard’ vary in reliability from condition to condition, study says
Private equity firm acquires Heritage Imaging
ACP Partners is buying the Boise, Idaho-based mobile diagnostic imaging provider for an undisclosed sum, planning to pursue further add-on deals.
International medical graduates represent nearly 25% of diagnostic radiologists in US
Recently policy changes under the Trump administration "highlight potential vulnerability in relying on this as a supply of radiologists," experts write in Academic Radiology.
Tuberculosis test may improve diagnosis
Researchers found that a new portable diagnostic test for tuberculosis produced rapid and accurate results.
Life Sciences Investment Opportunities Accelerate as AI and Genomics Drive $200+ Billion Market Expansion
“Covering more than 25 recently published reports, the review provides a consolidated view of growth opportunities across healthcare technologies, biologics, diagnostics and therapeutic markets.”Boston, June 01, 2026 (GLOBE NEWSWIRE) -- The global life sciences industry is experiencing unprecedented growth momentum across multiple therapeutic and diagnostic segments, with cumulative market opportunities exceeding $200 billion by 2030, according to BCC Research's latest comprehensive analysis. Th
Hopes £25m health hub will bring trade boost to Plymouth traders
The Community Diagnostics Centre in Plymouth's West End is due to open on 23 June.
Closing the diagnostics gap key to improving women's health
We must redesign women's health systems around early detection and integrated care, and recognize diagnostics as being foundational to effective care.
FinTech Pet Care Software Kennel Connection Brings Petwealth Pet Health Diagnostics to Pet Boarding & Daycare Expo West Following Strong Industry Reception at Intergroom
MOORPARK, Calif., May 26, 2026--Kennel Connection expands its exclusive Petwealth diagnostics partnership to Pet Boarding & Daycare Expo West following strong reception at Intergroom
Aspira Women’s Health and Cleveland Clinic Expand Strategic Collaboration to Advance AI-Powered Diagnostics in Women’s Health
Collaboration aims to accelerate biomarker discovery, strengthen translational research capabilities, and support scalable clinical validation
BioTools Innovator 2026 Cohort Includes Top 30 Life Science Tools and Diagnostics Companies
BioTools Innovator selected 30 life science startups for its 2026 Accelerator, with companies competing for $300K in funding.
Jardine to Buy Australian Imaging Firm I-MED in $2.4 Bilion Deal
Jardine Matheson Holdings Ltd. agreed to buy Australian medical diagnostic imaging provider I-MED Radiology Network Ltd. from private equity firm Permira, as the Asia-focused conglomerate seeks to expand its portfolio.
World Health Assembly endorses resolution on precision medicine
At the Seventy-ninth World Health Assembly, Member States endorsed a new resolution on Precision medicine: a path towards targeted, personalized and equitable care, taking an important step towards advancing precision medicine as part of efforts to strengthen equitable, effective and sustainable health systems. Precision medicine refers to the use of clinical, molecular, genomic and other health data to inform prevention, diagnosis and treatment, taking into account variability while applying appropriate ethical and legal safeguards. When integrated responsibly into health systems, precision approaches can improve outcomes across different disease areas and across the life course – from cancer and rare diseases to infectious diseases, maternal, newborn and child health, mental health and noncommunicable diseases. The resolution reflects rapid advances in genomics, diagnostics, data science and digital health, alongside widening global inequities in access to these innovations. Many populations – particularly in low- and middle-income countries – remain underrepresented in data and research, limiting the public health impact of precision medicine and risking the widening of health disparities if action is not taken now. "Precision medicine is not an aspirational idea for health delivery in the future – it is already transforming lives across the world. But its benefits remain out of reach for too many and the research driving progress is concentrated in high income countries. This WHA resolution gives global health leaders, ministries of health, and WHO a clear mandate: to act. From infant screening to setting up genomic databases WHO will work with countries to bring about the power of these innovations." Dr Meg Doherty, Director Science for HealthThrough the resolution, Member States commit to developing and strengthening national policies, infrastructure, workforce capacity and governance frameworks to support the safe, ethical and equitable integration of precision medicine into health systems, aligned with universal health coverage. This includes promoting affordability, ensuring inclusive research and data systems, strengthening regulation and data governance, and fostering collaboration across sectors and regions.WHO is requested to provide technical and normative support, review and coordinate existing guidance, facilitate global and regional collaboration, and develop a Global Strategy on Precision Medicine to guide equitable and context‑appropriate implementation. WHO stands ready to support Member States through tools such as a country maturity model for countries to self-assess capacity in implementing precision medicine depending on their context. In the immediate term WHO will map all existing guidance and frameworks and host extensive consultations with interest holders globally.By placing equity, inclusion and public value at the centre of precision medicine, the resolution reinforces WHO’s commitment to ensuring that scientific advances benefit all people, everywhere, and that no one is left behind in the next era of health innovation."By uniting people-centered healthcare with innovation, precision medicine has the potential to transform lives. This resolution helps ensure those advances serve the shared goal of health for all." Dr Sylvie Briand, Chief Scientist For further information please visit the Health Topic: Genomics
Barcelona Institute for Global Health: Expanded TB screening does not speed up treatment initiation or improve survival in hospitalised patients with HIV
Adding molecular tests on sputum, urine and stool samples does not appear to outperform the standard WHO-recommended diagnostic approach.
Innovation Developed by UT Health Sciences Research Program Passes Landmark Trial for Cardiac Amyloidosis
A new diagnostic tool developed at the University of Tennessee Health Sciences may soon make it significantly easier for physicians to detect cardiac amyloidosis, a progressive and frequently underdiagnosed disease caused by abnormal protein deposits in the heart.
Elliott builds big stake in life-science tools supplier Bio-Rad Labs, WSJ reports
Activist investor Elliott Investment Management has built a sizeable stake in U.S. diagnostics supplier Bio-Rad Laboratories NYSE:BIO, and plans to push the company to boost its underperforming stock price, the Wall Street Journal reported on Sunday.Bio-Rad's shares have fallen more than 18% so fa…
Lucid Diagnostics Provides Business Update and Reports First Quarter 2026 Financial Results
/PRNewswire/ -- Lucid Diagnostics Inc. (Nasdaq: LUCD) ("Lucid" or the "Company") a commercial-stage, cancer prevention medical diagnostics company, and...
How FMOL Health has positioned Baton Rouge at the forefront of sepsis diagnostics
FMOL Health has become the first health system in the world to deploy a breakthrough sepsis diagnostic technology across its entire network of hospitals. Executives say the Baton Rouge-developed i… Already an INSIDER? Sign in. Already an INSIDER? Sign in